product summary
Loading...
company name :
R&D Systems
product type :
protein
product name :
Recombinant Human CD30/TNFRSF8 Fc Chimera Protein, CF
catalog :
11155-CD-100
quantity :
100 ug
price :
468 USD
more info or order :
product information
master code :
11155-CD
SKU :
11155-CD-100
product name :
Recombinant Human CD30/TNFRSF8 Fc Chimera Protein, CF
unit size :
100 ug
description :
The Recombinant Human CD30/TNFRSF8 Fc Chimera Protein, CF from R&D Systems is derived from HEK293. The Recombinant Human CD30/TNFRSF8 Fc Chimera Protein, CF has been validated for the following applications: Bioactivity.
target :
CD30/TNFRSF8
category :
Proteins and Enzymes
buffer :
Lyophilized from a 0.2 ╡m filtered solution in PBS with Trehalose.
conjugate :
Unconjugated
purity :
>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie« Blue Staining.
species :
Human
observed molecular weight :
80-110 kDa, under reducing conditions.
theoretical molecular weight :
65 kDa
details of functionality :
Measured by its binding ability in a functional ELISA. When Recombinant Human CD30 Ligand/TNFSF8 (Catalog # 1028-CL ) is immobilized at 0.2 ╡g/mL (100 ╡L/well), Recombinant Human CD30/TNFRSF8 Fc Chimera (Catalog # 11155-CD) binds with an ED50 of 5.00-60.0 ng/mL.
endotoxin note :
<0.10 EU per 1 ╡g of the protein by the LAL method.
accessionNumbers :
P28908.1
applications :
Bioactivity
source long :
Human embryonic kidney cell, HEK293-derived human CD30/TNFRSF8 protein Human CD30 (Phe19-Lys379) Accession # P28908.1 IEGRMD Human IgG1 (Pro100-Lys330) N-terminus C-terminus
source short :
HEK293
USD :
468 USD
alt names :
CD30, CD30 antigen, CD30KI-1, CD30L receptor, cytokine receptor CD30, D1S166EKi-1, Ki-1 antigen, Lymphocyte activation antigen CD30, TNFRSF8, tumor necrosis factor receptor superfamily member 8, tumor necrosis factor receptor superfamily, member 8
storage :
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 ░C as supplied. 1 month, 2 to 8 ░C under sterile conditions after reconstitution. 3 months, -20 to -70 ░C under sterile conditions after reconstitution.
more info or order :
company information
R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com
800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.